Insys Therapeutics (INSY)

0.89 +0.07 (8.54%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/19 *Est.)

Latest Headlines

Janney Downgrades INSYS Therapeutics (INSY) to Neutral May 14, 2019 5:32 AM - StreetInsider Increasing unusual call option volume: PTC TUP QID MKC JEF FITB INSY PII WCG LAZ May 13, 2019 11:37 AM - StreetInsider Increasing unusual option volume: JEF QID GTLS INSY LAZ May 13, 2019 9:46 AM - StreetInsider Pre-Open Movers 05/13: (AMBR) (CPRX) (CLRB) Higher; (WFT) (INSY) (UBER) (more...) May 13, 2019 9:17 AM - StreetInsider Insys Therapeutics (INSY) Plunges After Bankruptcy Warning May 13, 2019 8:46 AM - StreetInsider Form NT 10-Q Insys Therapeutics, Inc. For: Mar 31 May 13, 2019 6:09 AM - SEC Filing Form 8-K Insys Therapeutics, Inc. For: May 10 May 13, 2019 6:07 AM - SEC Filing Form 10-Q Insys Therapeutics, Inc. For: Mar 31 May 13, 2019 6:02 AM - SEC Filing INSYS Therapeutics Reports First Quarter 2019 Results May 10, 2019 7:05 PM - Globe NewsWire Kapoor is Convicted of Plot to Drive Opioid Sales - Bloomberg May 2, 2019 2:34 PM - StreetInsider Form 10-K/A Insys Therapeutics, Inc. For: Dec 31 April 30, 2019 4:28 PM - SEC Filing Form SC 13G/A Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC April 29, 2019 12:37 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 04 Filed by: BOHLEN ELIZABETH April 23, 2019 7:17 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 04 Filed by: Mahboob Vaseem April 23, 2019 7:17 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Jan 25 Filed by: Nance Mark E April 23, 2019 7:16 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Apr 02 Filed by: Vanhove Geertrui April 23, 2019 7:15 PM - SEC Filing Form 3 Insys Therapeutics, Inc. For: Apr 02 Filed by: Vanhove Geertrui April 23, 2019 7:14 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Motahari Saeed April 23, 2019 7:13 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Long Andrew G April 23, 2019 7:12 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: MEYER STEVEN J April 23, 2019 7:11 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: LAPALME PIERRE April 23, 2019 7:09 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Vishnoi Rohit April 23, 2019 7:08 PM - SEC Filing Form 8-K/A Insys Therapeutics, Inc. For: Apr 14 April 23, 2019 5:22 PM - SEC Filing Form 8-K Insys Therapeutics, Inc. For: Apr 17 April 23, 2019 5:19 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Vishnoi Rohit April 19, 2019 9:47 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Long Andrew G April 19, 2019 9:43 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Motahari Saeed April 19, 2019 9:41 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Jan 25 Filed by: Nance Mark E April 19, 2019 9:39 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 04 Filed by: Mahboob Vaseem April 19, 2019 9:36 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 04 Filed by: BOHLEN ELIZABETH April 19, 2019 9:35 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: LAPALME PIERRE April 19, 2019 9:33 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: MEYER STEVEN J April 19, 2019 9:32 PM - SEC Filing Form 4 Insys Therapeutics, Inc. For: Apr 02 Filed by: Vanhove Geertrui April 19, 2019 9:31 PM - SEC Filing Form 3 Insys Therapeutics, Inc. For: Apr 02 Filed by: Vanhove Geertrui April 19, 2019 9:29 PM - SEC Filing Form 8-K Insys Therapeutics, Inc. For: Apr 14 April 18, 2019 5:21 PM - SEC Filing Insys Therapeutics (INSY) Appoints Andrew G. Long as CEO April 15, 2019 8:32 AM - StreetInsider INSYS Therapeutics Implements Leadership Changes April 15, 2019 8:30 AM - Globe NewsWire INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting March 25, 2019 6:00 AM - Globe NewsWire Insys Therapeutics (INSY) call put ratio 1 call to 1.3 puts as shares sell off 22% March 13, 2019 12:36 PM - StreetInsider Insys Therapeutics (INSY) Halted on LUDP March 13, 2019 9:54 AM - StreetInsider Insys Therapeutics (INSY) Declines After Filing 10-K, Includes Going Concern Statement March 13, 2019 9:53 AM - StreetInsider Form 10-K Insys Therapeutics, Inc. For: Dec 31 March 13, 2019 6:07 AM - SEC Filing INSYS Therapeutics (INSY) PT Lowered to $7 at RBC Capital March 8, 2019 6:29 AM - StreetInsider Insys Therapeutics (INSY) Misses Q4 EPS by 8c March 7, 2019 4:26 PM - StreetInsider INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results March 7, 2019 4:15 PM - Globe NewsWire Form 8-K Insys Therapeutics, Inc. For: Mar 07 March 7, 2019 4:14 PM - SEC Filing Form SC 13G/A Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC March 7, 2019 11:24 AM - SEC Filing INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7 March 6, 2019 4:15 PM - Globe NewsWire Form SC 13G/A Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC February 26, 2019 1:23 PM - SEC Filing Insys Therapeutics (INSY) Highlights Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment of Allergic Reactions (Type I) February 25, 2019 6:13 AM - StreetInsider INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis at American Academy of February 25, 2019 6:00 AM - Globe NewsWire Full Article List